Clinical Trial Update: A Controlled Trial to Assess the Immunogenicity of a Proposed Paediatric Dosing Schedule of Human Papillomavirus Vaccine [Phase 3]

View source ↗

Summary

This completed Phase 3 trial evaluated the immunogenicity of a proposed paediatric dosing schedule for the human papillomavirus (HPV) vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Genital Warts

Drugs mentioned

• HPV vaccine

Snippet

Sponsor: Simon Dobson | Conditions: Cervical Cancer, Genital Warts | Phase 3 | Status: COMPLETED